Literature DB >> 9059333

Angiogenesis and metastasis.

L M Ellis1, I J Fidler.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 9059333     DOI: 10.1016/s0959-8049(96)00389-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  68 in total

Review 1.  VEGF as a mediator of tumor-associated immunodeficiency.

Authors:  J E Ohm; D P Carbone
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials.

Authors:  Xue-Ning Ji; Sheng-Long Ye; Yan Li; Bo Tian; Jie Chen; Dong-Mei Gao; Jun Chen; Wei-Hua Bao; Yin-Kun Liu; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2003-08-26       Impact factor: 4.553

3.  Selection of more aggressive variants of the gI101A human breast cancer cell line: a model for analyzing the metastatic phenotype of breast cancer.

Authors:  Dina Chelouche Lev; Galina Kiriakova; Janet E Price
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

4.  Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth.

Authors:  Scott A Gerber; Viktoriya Y Rybalko; Chad E Bigelow; Amit A Lugade; Thomas H Foster; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 5.  The role of platelets in tumour growth.

Authors:  K Pilatova; L Zdrazilova-Dubska; G L Klement
Journal:  Klin Onkol       Date:  2012

Review 6.  Current status of anti-angiogenic agents in the treatment of ovarian carcinoma.

Authors:  Alfonso Sánchez-Muñoz; Elisabeth Pérez-Ruiz; César Mendiola Fernández; Emilio Alba Conejo; Antonio González-Martín
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

7.  Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant.

Authors:  Maolei Xu; Yun Xing; Ling Zhou; Xue Yang; Wenjun Yao; Wen Xiao; Chiyu Ge; Yanjun Ma; Jie Yang; Jie Wu; Rongyue Cao; Taiming Li; Jingjing Liu
Journal:  Tumour Biol       Date:  2013-03-01

8.  Prognostic value of microvascular density in dukes a and B (t1-t4, n0, m0) colorectal carcinomas.

Authors:  Rafael Uribarrena A; Javier Ortego; Javier Fuentes; Nuria Raventós; Pilar Parra; Rafael Uribarrena E
Journal:  Gastroenterol Res Pract       Date:  2009-11-04       Impact factor: 2.260

Review 9.  Intra-tumoural microvessel density in human solid tumours.

Authors:  J Hasan; R Byers; G C Jayson
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

10.  Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome.

Authors:  Jung-Chung Lin; Shuen-Kuei Liao; En-Huei Lee; Man-Shan Hung; Yiyang Sayion; Hung-Chang Chen; Chen-Chen Kang; Liang-Sheng Huang; Jaw-Ming Cherng
Journal:  J Biomed Sci       Date:  2009-11-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.